NCT02549339View on ClinicalTrials.gov

Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up

PHASE3CompletedINTERVENTIONAL
Enrollment

383

Participants

Timeline

Start Date

November 13, 2015

Primary Completion Date

August 5, 2016

Study Completion Date

August 10, 2017

Conditions
Actinic Keratosis
Interventions
DRUG

LEO 43204 gel

DRUG

Vehicle gel

Trial Locations (1)

46032

Laser & Skin Surgery Center of Indiana, Carmel

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY